Table 1.
Delivery Techniques for Gene Therapy
Gene Delivery Technique | Pro | Con |
---|---|---|
Myocardial injection24 | ●High density of gene transfer limited to cardiac muscle ●Simple and safe, able to inject percutaneously |
●Small area of gene expression ●Multiple injection sites needed ●Acute inflammatory response and potential scarring from the injection |
Coronary perfusion‐anterograde and retrograde perfusion | ●Delivers genes globally across the myocardium ●Distributes gene vector more homogeneously ●Cardiac specific |
●Inefficient ●Delivered into systemic circulation |
Aortic cross‐clamp LV cavity infusion4 | ●Increased gene transfer efficiency | ●Accessibility, need open chest ●High risk of myocardial injury ●Not cardiac specific |
Cardiopulmonary bypass perfusion and “closed‐loop” system25 | ●Specifically enhances coronary perfusion by separating it from systemic circulation ●Allows for temperature control of solution, cold increased transfection efficiency ●Increased contact time with gene vector through multiple‐pass cardiac recirculation |
●Significant morbidity risk from cardiopulmonary bypass procedure (CBP) ●Intended for patients undergoing CBP |
Epicardial painting23 | ●Cardiac specific ●Complete transmural penetration (atrial) ●High degree of gene transfer |
●Accessibility, currently needs open chest |
Ultrasound and microbubbles26 | ●Increased permeability of capillary and cell membrane | ●Only slightly improved gene transfer efficiency from myocardial injection alone |
Electroporation27 | ●Enhanced transfer of naked DNA via myocardial injection and retrograde perfusion ●Cardiac specific |
●Pulse needs to be delivered in sync or ventricular fibrillation occurs |
LV indicates left ventricle.